Product Information

GABAPENTIN 800 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0963 per EA under NDC 31722016701. Its NADAC has been published 224 times since Mar 16, 2022.

The High Outlier badge above means this manufacturer's average price in the Gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

GABAPENTIN 800 MG TABLET

Gabapentin
$0.0963per EA
High Outlier

Strength

800 mg/1

NDC

31722016701

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA214957

On Market Since

10/1/2021

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABAPENTIN 800 MG TABLET has been published 224 times since Mar 16, 2022, and over the history we have for it it has declined 23.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0963 per EA
All-time high$0.1308 (Mar 15, 2023)
All-time low$0.0799 (Nov 20, 2024)
52-week high$0.1035
52-week low$0.0963
Median price$0.1171
Average price$0.1127
Largest weekly change-27.0% (Nov 20, 2024)
Weeks tracked224
Tracking sinceMar 16, 2022

Price History

1W

0.0%

1M

-1.7%

3M

-3.0%

6M

-3.7%

1Y

-7.0%

3Y

-26.1%

5Y

N/A

All

-23.9%

Generic Alternatives

The matcher finds 21 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of GABAPENTIN 800 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 800 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.0963 per EA (NDC 31722016701), effective Jun 24, 2026.

How has the price of GABAPENTIN 800 MG TABLET changed over time?

Over the history we have for it, the NADAC for GABAPENTIN 800 MG TABLET has declined 23.9%. It has been tracked across 224 weekly CMS publications since Mar 16, 2022.

What are the highest and lowest recorded NADAC prices for GABAPENTIN 800 MG TABLET?

Since Mar 16, 2022, the NADAC for GABAPENTIN 800 MG TABLET has ranged from a low of $0.0799 (Nov 20, 2024) to a high of $0.1308 (Mar 15, 2023), with a median of $0.1171 per EA.

Are there cheaper alternatives to GABAPENTIN 800 MG TABLET?

21 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 800 MG TABLET, but none are currently priced below it.

Who manufactures GABAPENTIN 800 MG TABLET?

GABAPENTIN 800 MG TABLET (NDC 31722016701) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.